Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Capital Expenditures history
Currency unavailable · from the cash flow
No Capital Expenditures data reported for this period type.
Capital Expenditures vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $25.26M USD | +86.4% | +29.8% | 35.6% | |
| FY2025 | $1.45M USD | — | — | 7.8% | |
| LTM Mar 2026 | $452.02K USD | — | -62.0% | — | |
| LTM Jun 2026 | $260K USD | +42.9% | +3.6% | 3.7% | |
| LTM Mar 2026 | $246K USD | -70.9% | -68.9% | 109.3% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +42.9% | -29.2% | 21.7% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.